SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
小药师
Lv3
320 积分
2023-10-31 加入
最近求助
最近应助
互助留言
Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: A case series
4天前
已完结
New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database
9天前
已完结
Unusual progression to erythroderma after initiation of dupilumab
13天前
已完结
Dupilumab‐induced psoriatic erythroderma with characteristic cytokine and antimicrobial peptide expression pattern in a patient with long standing atopic dermatitis
13天前
已完结
Characterizing Adverse Events of Biologic Treatment of T2 Disease: A Disproportionality Analysis of the FDA Adverse Event Reporting System
13天前
已完结
Characterizing Adverse Events of Biologic Treatment of T2 Disease: A Disproportionality Analysis of the FDA Adverse Event Reporting System
13天前
已完结
Erythema, pruritus, and diffuse peeling of skin during dupilumab therapy for atopic dermatitis in three adults
14天前
已完结
Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system
14天前
已完结
Tralokinumab in Atopic Dermatitis: A Profile of Its Use
14天前
已完结
Safety of tralokinumab in atopic dermatitis
15天前
已关闭
没有进行任何应助
感谢,速度真快,帮大忙了
4天前
感谢,点赞,速度真快,帮大忙了
9天前
感谢,速度真快,帮大忙了
13天前
点赞,速度真快,帮大忙了
13天前
感谢,点赞,速度真快
13天前
感谢,点赞,速度真快,帮大忙了
13天前
速度真快,帮大忙了
14天前
感谢,点赞,速度真快,帮大忙了
14天前
帮大忙了,速度真快
14天前
感谢,速度真快,帮大忙了,么么哒
15天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论